open access

Vol 16, No 6 (2009)
Original articles
Published online: 2009-11-19
Get Citation

Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: The effect on blood pressure in patients with renovascular hypertension

Andrzej Lekston, Jerzy Chudek, Krzysztof Wilczek, Mariusz Gąsior, Andrzej Więcek, Franciszek Kokot, Marek Fijałkowski, Marek Gierlotka, Bożena Szyguła-Jurkiewicz, Roman Wojnicz, Brygida Białas, Marcin Osuch, Bogusław Maciejewski, Lech Poloński
Cardiol J 2009;16(6):514-520.

open access

Vol 16, No 6 (2009)
Original articles
Published online: 2009-11-19

Abstract

Background: Scarce data exist concerning the long-term effect of percutaneous transluminal renal angioplasty (PTRA) enhanced with intravascular gamma brachytherapy (IVBT) in patients with renovascular hypertension.
Methods: Seventy one patients aged 52 ± 8 years with refractory renovascular hypertension were randomized to Group I (PTRA + IVBT) or Group II (PTRA). For the IVBT procedure, the PARIS catheter and Microselectron HDR (Nucletron) system was employed. Both baseline and 9-month follow-up quantitative computerized angiography (QCA) and ambulatory blood pressure monitoring analysis was performed to assess luminal parameters of restenosis and the effect of treatment on blood pressure.
Results: Thirty three patients from Group I and 29 patients from Group II underwent successful procedure. During nine months of follow-up, three patients died; including two patients in Group I (cardiac causes) and one patient in Group II (stroke). The follow-up lumen diameter stenosis was 30.6 ± 13.7% and 40.4 ± 11% in Groups I and II, respectively (p = 0.004). Late lumen loss in quantitative computerized angiography was 1.2 ± 0.7 mm and 1.7 ± 0.7 mm in Groups I and II, respectively (p = 0.004). Conclusions: Intravascular gamma brachytherapy using self-centering source performed after balloon angioplasty is a safe and effective method of prevention of restenosis after PTRA in patients with renovascular hypertension.

Abstract

Background: Scarce data exist concerning the long-term effect of percutaneous transluminal renal angioplasty (PTRA) enhanced with intravascular gamma brachytherapy (IVBT) in patients with renovascular hypertension.
Methods: Seventy one patients aged 52 ± 8 years with refractory renovascular hypertension were randomized to Group I (PTRA + IVBT) or Group II (PTRA). For the IVBT procedure, the PARIS catheter and Microselectron HDR (Nucletron) system was employed. Both baseline and 9-month follow-up quantitative computerized angiography (QCA) and ambulatory blood pressure monitoring analysis was performed to assess luminal parameters of restenosis and the effect of treatment on blood pressure.
Results: Thirty three patients from Group I and 29 patients from Group II underwent successful procedure. During nine months of follow-up, three patients died; including two patients in Group I (cardiac causes) and one patient in Group II (stroke). The follow-up lumen diameter stenosis was 30.6 ± 13.7% and 40.4 ± 11% in Groups I and II, respectively (p = 0.004). Late lumen loss in quantitative computerized angiography was 1.2 ± 0.7 mm and 1.7 ± 0.7 mm in Groups I and II, respectively (p = 0.004). Conclusions: Intravascular gamma brachytherapy using self-centering source performed after balloon angioplasty is a safe and effective method of prevention of restenosis after PTRA in patients with renovascular hypertension.
Get Citation

Keywords

brachytherapy; renal artery stenosis; atherosclerosis; percutaneous transluminal renal angioplasty; hypertension

About this article
Title

Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: The effect on blood pressure in patients with renovascular hypertension

Journal

Cardiology Journal

Issue

Vol 16, No 6 (2009)

Pages

514-520

Published online

2009-11-19

Bibliographic record

Cardiol J 2009;16(6):514-520.

Keywords

brachytherapy
renal artery stenosis
atherosclerosis
percutaneous transluminal renal angioplasty
hypertension

Authors

Andrzej Lekston
Jerzy Chudek
Krzysztof Wilczek
Mariusz Gąsior
Andrzej Więcek
Franciszek Kokot
Marek Fijałkowski
Marek Gierlotka
Bożena Szyguła-Jurkiewicz
Roman Wojnicz
Brygida Białas
Marcin Osuch
Bogusław Maciejewski
Lech Poloński

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl